Fresenius Medical Care AG & Co. KGaA received a Sell rating and a €38.00 price target from Bank of America Securities analyst Anna Ractliffe today. The company’s shares closed yesterday at €47.55.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
According to TipRanks, Ractliffe is a 2-star analyst with an average return of 11.8% and a 75.00% success rate.
The word on The Street in general, suggests a Hold analyst consensus rating for Fresenius Medical Care AG & Co. KGaA with a €45.00 average price target, implying a -5.36% downside from current levels. In a report released yesterday, Morgan Stanley also maintained a Sell rating on the stock with a €41.00 price target.
Based on Fresenius Medical Care AG & Co. KGaA’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of €4.79 billion and a net profit of €225.27 million. In comparison, last year the company earned a revenue of €4.77 billion and had a net profit of €187 million
/A%20concept%20image%20of%20space_%20Image%20by%20Canities%20via%20Shutterstock_.jpg)
/A%20concept%20image%20of%20a%20flying%20car_%20Image%20by%20Phonlamai%20Photo%20via%20Shutterstock_.jpg)
/Oracle%20Corp_%20office%20logo-by%20Mesut%20Dogan%20via%20iStock.jpg)